Ocular Therapeutix
OCUL
#4995
Rank
โ‚ฌ1.42 B
Marketcap
6,55ย โ‚ฌ
Share price
-6.44%
Change (1 day)
-6.54%
Change (1 year)

Revenue for Ocular Therapeutix (OCUL)

Revenue in 2025 (TTM): โ‚ฌ44.97 Million

According to Ocular Therapeutix's latest financial reports the company's current revenue (TTM ) is โ‚ฌ45.03 Million. a decrease over the revenue in the year 2024 that were of โ‚ฌ61.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ocular Therapeutix from 2014 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ44.22 M-27.78%
2024 โ‚ฌ61.23 M15.83%
2023 โ‚ฌ52.86 M10.13%
2022 โ‚ฌ48 M24.92%
2021 โ‚ฌ38.42 M171.6%
2020 โ‚ฌ14.14 M274.97%
2019 โ‚ฌ3.77 M116.92%
2018 โ‚ฌ1.73 M8.54%
2017 โ‚ฌ1.6 M-10.66%
2016 โ‚ฌ1.79 M12.09%
2015 โ‚ฌ1.6 M152.14%
2014 โ‚ฌ0.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
SurModics
SRDX
โ‚ฌ0.10 B 132.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
โ‚ฌ70.14 M 55.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
โ‚ฌ92.54 M 105.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚ฌ1.14 B 2,437.54%๐Ÿ‡บ๐Ÿ‡ธ USA